semaj83/ctmatch_classification huggingface dataset:
Patient description: A 67-year-old healthy woman came to the clinic to have her flu shot in early October. She works at a rehab center and has no underlying disease. It is her first vaccination this year. she is menopausal and has 4 children. She does not some. She takes daily multivitamins and anti-hypertensive drugs. She exercises regularly for 30 minutes a day at least 5 days a week. She has no allergies to any food or drugs.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Influenza Subjects who, in the opinion of the investigator, can and will comply with the requirements of the protocol A male or female 18 years of age and older at the time of the first vaccination Written informed consent obtained from the subject Healthy subjects as established by medical history and clinical examination before entering into the study Female subjects of non-childbearing potential may be enrolled in the study Female subjects of childbearing potential may be enrolled in the study, if the subject has practiced adequate contraception for 30 days prior to vaccination, and has a negative pregnancy test on the day of vaccination, and has agreed to continue adequate contraception during the entire treatment period and for 2 months after completion of the vaccination  Use of any investigational or non-registered product (drug or vaccine) other than the study vaccine within 30 days preceding the dose of study vaccine, or planned use during the study period Administration of any influenza vaccine within 6 months preceding the study start or planned use of such vaccines during the study period Administration of any other vaccine(s) within 30 days prior to study enrolment or during the study period Clinically or virologically confirmed influenza infection within the six months preceding the study vaccination Acute disease and/or fever at the time of enrolment Significant acute or chronic, uncontrolled medical or psychiatric or neurological illness Any confirmed or suspected immunosuppressive or immunodeficient condition Acute or chronic, clinically significant pulmonary, cardiovascular, hepatic or renal functional abnormality, as determined by physical examination or laboratory screening tests Insulin-dependent diabetes mellitus Presence of blood dyscrasias, including hemoglobinopathies and myelo
Patient description: A 67-year-old healthy woman came to the clinic to have her flu shot in early October. She works at a rehab center and has no underlying disease. It is her first vaccination this year. she is menopausal and has 4 children. She does not some. She takes daily multivitamins and anti-hypertensive drugs. She exercises regularly for 30 minutes a day at least 5 days a week. She has no allergies to any food or drugs.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Chronic Kidney Disease End Stage Renal Disease Anemia Minimum age 18 years 2. Completed the Treatment Period of an ongoing FG-4592 FibroGen-sponsored anemia study in the U.S  Subjects assigned to epoetin alfa in a previous ongoing FG-4592 anemia study 2. Pregnant or breastfeeding females 3. Females of childbearing potential, unless using contraception as detailed in the protocol; male subjects with sexual partners of childbearing potential who are not on birth control unless the male subject agrees to use contraception 4. Subjects who received FG-4592 in a previous study that did not demonstrate adequate hemoglobin response per the investigator's clinical judgment 5. Any medical condition that in the opinion of the investigator may pose a safety risk to a subject in this study, or which may interfere with study participation
Patient description: A 67-year-old healthy woman came to the clinic to have her flu shot in early October. She works at a rehab center and has no underlying disease. It is her first vaccination this year. she is menopausal and has 4 children. She does not some. She takes daily multivitamins and anti-hypertensive drugs. She exercises regularly for 30 minutes a day at least 5 days a week. She has no allergies to any food or drugs.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Eosinophilic Esophagitis Food Allergies Male and female subjects 18 years and older 2. Previous diagnosis of eosinophilic esophagitis with clinical symptoms including heartburn, dysphagia, vomiting, epigastric pain, recurrent vomiting, food impaction as well > 15 eosinophils per high powered field (400x magnification) by endoscopic esophageal biopsy in both the proximal and distal esophagus 3. Previous diagnosis of gastroesophageal reflux with < 15 eosinophils per high powered field (400x magnification) by endoscopic biopsy  Male and female subjects less than 18 years of age 2. Pregnant female subjects 3. Subjects who are receiving systemic steroids and are unable to stop prior to enrollment 4. Subjects who are receiving systemic antihistamines and are unable to stop prior to enrollment 5. Subjects who are unable to cooperate/comply with study procedures or communicate with investigator in order to successfully complete the study 6. Subjects with severe skin disorders such as atopic dermatitis, dermatographism, or psoriasis who would be unable to complete skin or patch testing 7. Subjects with an infirmity, disability, or geographical location which seems likely to prevent regular attendance for patient visit -
Patient description: A 67-year-old healthy woman came to the clinic to have her flu shot in early October. She works at a rehab center and has no underlying disease. It is her first vaccination this year. she is menopausal and has 4 children. She does not some. She takes daily multivitamins and anti-hypertensive drugs. She exercises regularly for 30 minutes a day at least 5 days a week. She has no allergies to any food or drugs.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Sickle Cell Diabetes Cancer Cardiovascular Disease Genetic Screening Aged 18 years or older Ability to complete in-person, web-based or telephone survey/interview(s) Ability to read English or Spanish (in some cases) Affected by or have at least one first or second-degree relative affected by or have a spouse/partner affected by the disease(s) of interest OR Biological or non-biological (e.g. adopted or step) relative of the primary participant or spouse/partner of the primary participant or biological relative of primary participant  Individuals with cognitive difficulties will be excluded from the study, as participants will be required to comprehend and legally consent to participation in this study and complete the survey/interview(s)
Patient description: A 67-year-old healthy woman came to the clinic to have her flu shot in early October. She works at a rehab center and has no underlying disease. It is her first vaccination this year. she is menopausal and has 4 children. She does not some. She takes daily multivitamins and anti-hypertensive drugs. She exercises regularly for 30 minutes a day at least 5 days a week. She has no allergies to any food or drugs.

Clinical trial eligibility criteria: eligible ages (years): 0.417-1.417,  Malaria Healthy infant/child aged 5-17 months at the time of first study vaccination 2. Informed consent of parent/guardian 3. Infant / child and parent/guardian resident in the study area villages and anticipated to be available for vaccination and follow-up  Clinically significant skin disorder (psoriasis, contact dermatitis etc.), immunodeficiency, cardiovascular disease, respiratory disease, endocrine disorder, liver disease, renal disease, gastrointestinal disease, neurological illness Weight-for-age Z score of less than -3 or other clinical signs of malnutrition History of allergic reaction, significant IgE-mediated event, or anaphylaxis to immunisation History of allergic disease or reactions likely to be exacerbated by any component of the vaccines, e.g. egg products, Kathon, neomycin, beta-propiolactone Haemoglobin less than 8.0 g/dL, where judged to be clinically significant in the opinion of the investigator Serum Creatinine concentration greater than 70 µmol/L, where judged to be clinically significant in the opinion of the investigator Serum ALT concentration greater than 45 U/L, where judged to be clinically significant in the opinion of the investigator Blood transfusion within one month of enrolment Previous vaccination with experimental malaria vaccines Administration of any other vaccine or immunoglobulin less than one week before vaccination with any study vaccine
Patient description: A 67-year-old healthy woman came to the clinic to have her flu shot in early October. She works at a rehab center and has no underlying disease. It is her first vaccination this year. she is menopausal and has 4 children. She does not some. She takes daily multivitamins and anti-hypertensive drugs. She exercises regularly for 30 minutes a day at least 5 days a week. She has no allergies to any food or drugs.

Clinical trial eligibility criteria: eligible ages (years): 18.0-60.0,  Enhancement of Protective Antibody Response After Probiotic Consumption healthy male and female adult between 18 and 60 years old non menopausal female( with effective contraception) female non pregnant not wishing to be pregnat during the study capable to respect the protocol affialted to the social security system aggreeing to be registered in the national fileof volunteers  food allergy( component of the experimental product vaccines) manifestation of allergy vaccinated against flu during the 2 previous winters Food allergy, allergy to one of the component of the experimental products or allergy to one of the component of the flu vaccine Subject displaying manifestation of allergy or being treated for these Subject vaccinated against flu during the 2 previous winter (winter 2009-2010 and winter 2010-2011) Subject who had symptoms evocating flu during the previous winter (winter 2010-2011) Subject immunodepressed Subject with immunomodulatory treatment
Patient description: A 67-year-old healthy woman came to the clinic to have her flu shot in early October. She works at a rehab center and has no underlying disease. It is her first vaccination this year. she is menopausal and has 4 children. She does not some. She takes daily multivitamins and anti-hypertensive drugs. She exercises regularly for 30 minutes a day at least 5 days a week. She has no allergies to any food or drugs.

Clinical trial eligibility criteria: eligible ages (years): 65.0-999.0,  Influenza Residents of one of the participating LTC sites years or older at the time of consent require assistance in two or more Instrumental Activities of Daily Living and/or one or more Activities of Daily Living as identified by facility staff  Age less than 65 years Life expectancy less than 6 months History of allergic reaction to influenza vaccine, its components, or eggs History of severe allergic reaction to latex History of Guillian-Barre Syndrome Actively undergoing chemotherapy Actively undergoing radiation therapy Use of prednisone (or other steroid) at prednisone-equivalent dosages of 10mg or higher within the past 14 days Serious current immunosuppression or immunosuppression expected in the next 6 weeks Any condition that, in the opinion of the investigator,might interfere with the evaluation of study objectives
Patient description: A 67-year-old healthy woman came to the clinic to have her flu shot in early October. She works at a rehab center and has no underlying disease. It is her first vaccination this year. she is menopausal and has 4 children. She does not some. She takes daily multivitamins and anti-hypertensive drugs. She exercises regularly for 30 minutes a day at least 5 days a week. She has no allergies to any food or drugs.

Clinical trial eligibility criteria: eligible ages (years): 0.5-999.0,  Influenza participants were enrolled (toddlers: 6 months to 3 years; school-aged children: 6 to 12 years and older adults: ≥60 years） Eligible participants were generally healthy or had stable chronic medical conditions (for older adults only)  History of allergic reaction to any component of the study vaccines or previous influenza vaccine History of systemic hypersensitivity to hens' eggs History of Guillain Barré syndrome following administration of any influenza vaccine Any immunodeficient or immunocompromised conditions Receipt of cytotoxic or immunosuppressive drugs within the past 6 months Receipt of blood-derived product within the past 3 months Receipt of any vaccine within one month prior to study entry with exception of paediatric routine vaccination Receipt of non-study 2010-2011 seasonal TIV Participation in any other study with a non-approved drug during the study Acute febrile disease and other self-limiting illness were the temporary
Patient description: A 67-year-old healthy woman came to the clinic to have her flu shot in early October. She works at a rehab center and has no underlying disease. It is her first vaccination this year. she is menopausal and has 4 children. She does not some. She takes daily multivitamins and anti-hypertensive drugs. She exercises regularly for 30 minutes a day at least 5 days a week. She has no allergies to any food or drugs.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Parent Attitudes Parents of dehydrated children aged 0-18  Child with severe dehydration Child with chronic disease causing dehydration
Patient description: A 67-year-old healthy woman came to the clinic to have her flu shot in early October. She works at a rehab center and has no underlying disease. It is her first vaccination this year. she is menopausal and has 4 children. She does not some. She takes daily multivitamins and anti-hypertensive drugs. She exercises regularly for 30 minutes a day at least 5 days a week. She has no allergies to any food or drugs.

Clinical trial eligibility criteria: eligible ages (years): 18.0-49.0,  Influenza Male or female aged 18 years Give written informed consent Healthy, as determined by medical history, physical examination, vital signs, and clinical safety laboratory examinations Females should not be pregnant and not lactating and fulfill one of the following At least one year post-menopausal;Surgically sterile;Will use oral, implantable, transdermal or injectable contraceptives for 30 days prior to first vaccination and until 28 days after vaccination Willing to use another reliable form of contraception approved by the Investigator for study duration and until 28 days after vaccination Women of childbearing potential must have a negative urine pregnancy test within 24 hours preceding receipt of vaccination Comprehension of the study requirements, expressed availability for the required study period, and ability to attend scheduled visits Willing to receive the unlicensed (VAX161) vaccine given as an i.m. injection Willing to provide multiple blood specimens collected by venipuncture
Patient description: A 67-year-old healthy woman came to the clinic to have her flu shot in early October. She works at a rehab center and has no underlying disease. It is her first vaccination this year. she is menopausal and has 4 children. She does not some. She takes daily multivitamins and anti-hypertensive drugs. She exercises regularly for 30 minutes a day at least 5 days a week. She has no allergies to any food or drugs.

Clinical trial eligibility criteria: eligible ages (years): 18.0-80.0,  Hypertension Caucasian patients aged 18-80 years History of any grade of hypertension for at least 1 year, including at least 3 months of constant antihypertensive medication (consisting of ≥ 1 antihypertensive drugs, each administered in one dose daily), with reasonably controlled BP (≤150/90 mmHg and ≥ 115/75 mmHg on usual medication) based on previous clinic records, in the last 3 months  BP levels > 150/90 mmHg or < 115/75 mmHg in the last 3 months Postural hypotension, defined as symptoms resulting from a > 20 mm Hg drop of systolic BP or a > 10 mm Hg drop of diastolic BP or both between 1 and 3 min after standing from the sitting position Known Extreme dippers at baseline (fall of mean night time SBP > 20% of mean day time SBP) Individuals with jobs which require night-time shift work Pregnant women or those planning to become pregnant
Patient description: A 67-year-old healthy woman came to the clinic to have her flu shot in early October. She works at a rehab center and has no underlying disease. It is her first vaccination this year. she is menopausal and has 4 children. She does not some. She takes daily multivitamins and anti-hypertensive drugs. She exercises regularly for 30 minutes a day at least 5 days a week. She has no allergies to any food or drugs.

Clinical trial eligibility criteria: eligible ages (years): 19.0-999.0,  HIV Infection Adult men and women aged 19 years or over 2. HIV positive by ELISA and Western blot, at least 3 months prior to screening 3. No antiretroviral therapy within 3 months prior to screening 4. Plasma HIV RNA (viral load) > 2,500 copies/mL at screening 5. Current CD4 cell count >350 cells/mm3 at screening 6. Adequate renal function as demonstrated by eGFR >60 mL/min. at screening  Pregnancy or breast-feeding 2. Any HIV-associated symptom or condition (e.g. nephropathy) for which standard antiretroviral therapy is indicated immediately 3. History of peptic ulcer and/or gastrointestinal bleeding 4. Allergy to ASA, other salicylates, or NSAIDs 5. Currently receiving treatment with an ACE inhibitor, ASA, anticoagulants, antacids containing aluminum hydroxide, cyclosporine, diuretics, systemic glucocorticoids, lithium, methotrexate, or other NSAIDs 6. Significant hepatic impairment or active liver disease screening AST, ALT, or bilirubin >2.5x upper limit of normal (ULN) 7. Hyperkalemia screening serum potassium >5.5 mmol/L 8. Anemia screening hemoglobin <85 g/L
Patient description: A 67-year-old healthy woman came to the clinic to have her flu shot in early October. She works at a rehab center and has no underlying disease. It is her first vaccination this year. she is menopausal and has 4 children. She does not some. She takes daily multivitamins and anti-hypertensive drugs. She exercises regularly for 30 minutes a day at least 5 days a week. She has no allergies to any food or drugs.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Influenza Subject is ≥ 18 years of age on the day of Informed consent form has been signed and dated Able to attend all scheduled visits and to comply with all trial procedures  History of serious adverse reaction to any influenza vaccine Receipt of any vaccine within 30 days before receiving study vaccine, or plans to receive another vaccine before Visit 2 Participation in another interventional clinical trial investigating a vaccine, drug, medical device, or medical procedure in the 30 days preceding the first study vaccination or during the course of the study, unless no intervention for the other study occurred within the 30 days prior to the first study vaccination and none are planned before the subject would complete safety surveillance for the present study Thrombocytopenia, which may be a contraindication for intramuscular vaccination, at the discretion of the Investigator Prior vaccination with any 2012 formulation of influenza vaccine Known systemic hypersensitivity to eggs, chicken proteins, latex, or any of the vaccine components, or a history of a life-threatening reaction to Fluzone, Fluzone Intradermal, or Fluzone High-Dose vaccine or to a vaccine containing any of the same substances (the complete list of vaccine components is included in the Prescribing Information) Receipt of immune globulins, blood, or blood-derived products in the past 3 months Bleeding disorder or receipt of anticoagulants in the 3 weeks preceding which may be a contraindication for intramuscular vaccination, at the discretion of the Investigator Subject is pregnant, or lactating, or of childbearing potential (to be considered of non-childbearing potential, a female must be pre-menarche or post-menopausal for at least 1 year, surgically sterile, or using an effective method of contraception or abstinence from at least 4 weeks prior to vaccination and until at least 4 weeks after vaccination)
Patient description: A 67-year-old healthy woman came to the clinic to have her flu shot in early October. She works at a rehab center and has no underlying disease. It is her first vaccination this year. she is menopausal and has 4 children. She does not some. She takes daily multivitamins and anti-hypertensive drugs. She exercises regularly for 30 minutes a day at least 5 days a week. She has no allergies to any food or drugs.

Clinical trial eligibility criteria: eligible ages (years): 18.0-64.0,  Influenza Aged 18 through 64 years on the day of Informed consent form (ICF) has been signed and dated Able to attend all scheduled visits and to comply with all trial procedures Subject is pregnant, or lactating, or of childbearing potential (to be considered of non-childbearing potential, a female must be post-menopausal for at least 1 year, surgically sterile, or using an effective method of contraception or abstinence from at least 4 weeks prior to vaccination and until at least 4 weeks after vaccination) Participation at the time of trial enrollment (or in the 4 weeks preceding the trial vaccination) or planned participation during the present trial period in another clinical trial investigating a vaccine, drug, medical device, or medical procedure Receipt of any vaccine in the 4 weeks preceding the trial vaccination or planned receipt of any vaccine in the 4 weeks following trial vaccination Vaccination against influenza in the past 6 months Receipt of immune globulins, blood or blood-derived products in the past 3 months Known or suspected congenital or acquired immunodeficiency; or receipt of immunosuppressive therapy, such as anti-cancer chemotherapy or radiation therapy, within the preceding 6 months; or long-term systemic corticosteroid therapy (prednisone or equivalent for more than 2 consecutive weeks within the past 3 months) Known systemic hypersensitivity to any of the vaccine components, or history of a life-threatening reaction to the vaccine used in the trial or to a vaccine containing any of the same substances
Patient description: A 67-year-old healthy woman came to the clinic to have her flu shot in early October. She works at a rehab center and has no underlying disease. It is her first vaccination this year. she is menopausal and has 4 children. She does not some. She takes daily multivitamins and anti-hypertensive drugs. She exercises regularly for 30 minutes a day at least 5 days a week. She has no allergies to any food or drugs.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Consequences of Immunization Method healthy adults without latex allergy over 18 years of age  latex allergy illness years or less
Patient description: A 67-year-old healthy woman came to the clinic to have her flu shot in early October. She works at a rehab center and has no underlying disease. It is her first vaccination this year. she is menopausal and has 4 children. She does not some. She takes daily multivitamins and anti-hypertensive drugs. She exercises regularly for 30 minutes a day at least 5 days a week. She has no allergies to any food or drugs.

Clinical trial eligibility criteria: eligible ages (years): 18.0-80.0,  Parkinson's Disease Patients with Parkinson's disease Age between 18-80 years Patients signed the consent form  Patients with atypical parkinsonism